Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
21.12
+0.07 (0.33%)
May 23, 2025, 2:45 PM CST
SHE:300482 Revenue
Guangzhou Wondfo Biotech Co.,Ltd had revenue of 800.28M CNY in the quarter ending March 31, 2025, a decrease of -7.06%. This brings the company's revenue in the last twelve months to 3.00B, up 7.50% year-over-year. In the year 2024, Guangzhou Wondfo Biotech Co.,Ltd had annual revenue of 3.06B with 10.85% growth.
Revenue (ttm)
3.00B
Revenue Growth
+7.50%
P/S Ratio
3.36
Revenue / Employee
939.63K
Employees
3,197
Market Cap
10.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.06B | 299.90M | 10.85% |
Dec 31, 2023 | 2.76B | -2.92B | -51.33% |
Jan 1, 2023 | 5.68B | 2.32B | 69.01% |
Dec 31, 2021 | 3.36B | 550.20M | 19.57% |
Dec 31, 2020 | 2.81B | 738.52M | 35.64% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |